5-amino-1mq dosage oral subcutaneous biohacking 5 Amino1MQ 5 Amino 1 Dose Protocol
Description
It is not a GLP-1, not a weight-loss drug, and should not be treated as one
The peptide did not produce adverse metabolic effects associated with full-length growth hormone, including insulin resistance, glucose intolerance, or IGF-1 elevation
No FDA status Not FDA-approved Compound Semaglutide Mechanism GLP-1 receptor agonist
Were happy to share case examples.
